Evidence map›Paper›PMID 29785014›Full record

ArticleNature genetics2018

3' UTR shortening represses tumor-suppressor genes in trans by disrupting ceRNA crosstalk.

Hyun Jung Park, Ping Ji, Soyeon Kim, Zheng Xia, Benjamin Rodriguez, Lei Li, Jianzhong Su, Kaifu Chen, Chioniso P Masamha, David Baillat and 5 more

Abstract read
In one paragraph

Article in Nature genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed
10.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 197 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Characterization and molecular targeting of CFIm25 (NUDT21/CPSF5) mRNA using miRNAs.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Hyun Jung ParkDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Ping JiDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Soyeon KimCenter for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Zheng XiaDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Benjamin RodriguezDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Lei LiDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.ORCID http://orcid.org/0000-0003-3924-2544
Jianzhong SuDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Kaifu ChenDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA.
Chioniso P MasamhaDepartment of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA.ORCID http://orcid.org/0000-0002-2427-786X
David BaillatDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Camila R Fontes-GarfiasDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.
Ann-Bin ShyuDepartment of Biochemistry and Molecular Biology, University of Texas, McGovern Medical School, Houston, TX, USA.
Joel R NeilsonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Eric J WagnerDepartment of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. ejwagner@utmb.edu.
Wei LiDivision of Biostatistics, Dan L Duncan Cancer Center, Baylor College of Medicine, Houston, TX, USA. WL1@bcm.edu.ORCID http://orcid.org/0000-0001-9931-5990
Baylor College of Medicine · USThe University of Texas Medical Branch at Galveston · USThe University of Texas Health Science Center at Houston · USButler University · USUniversity of Pittsburgh · US

Funding

Systems Analysis of Epigenomic Architecture in Cancer ProgressionU54CA217297 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI HUANG, TIM H.-M. · 2017 to 2021
$9.3M
Messenger RNA Turnover in Mammalian CellsR01GM046454 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SHYU, ANN-BIN · 1991 to 2016
$7.1M
Computational and Experimental Modeling of Alternative PolyadenylationR01CA193466 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2016 to 2025
$3.3M
Regulation of Messenger RNA Turnover in Mammalian CellsR35GM127109 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI SHYU, ANN-BIN · 2018 to 2022
$2.3M
Computational and Experimental Modeling of Epigenetic DNA MethylationR01HG007538 · NHGRI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LI, WEI · 2014 to 2018
$1.9M
In Silico Screening of Alternative Polyadenylation Regulators in CancersK01LM012877 · NLM · OREGON HEALTH & SCIENCE UNIVERSITY · PI XIA, ZHENG · 2018 to 2020
$428k
NCI NIH HHS R01 CA193466NCI NIH HHS U54 CA217297NHGRI NIH HHS R01 HG007538NIGMS NIH HHS R01 GM046454NIGMS NIH HHS R35 GM127109NLM NIH HHS K01 LM012877
6 · The paper itself

Abstract

Widespread mRNA 3' UTR shortening through alternative polyadenylation

Indexed as

3' Untranslated RegionsGenes, Tumor SuppressorCell Line, TumorGene Expression Regulation, NeoplasticHeLa CellsHumansMCF-7 CellsMicroRNAsNeoplasmsProto-Oncogene MasProto-OncogenesRNARNA, Messenger3' Untranslated RegionsMAS1 protein, humanMicroRNAsProto-Oncogene MasRNARNA, Messenger

Identifiers

PMID29785014
PMCPMC6689271
OpenAlexW2804265440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.